Intensity Therapeutics, Inc.
INTSCIK 0001567264 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
4,781 bought / 0 sold
net +4,781 sh · +$16.7K
- buys
- 2
- sells
- 0
- insiders active
- 2
Filing tape
Filed Wed, Jul 1, 2026
- +3,688 sh · $12.9K
Wesolowski John M — Principal Accounting Officer
- Granted3,688Common Stock, $0.0001 Par Value@ $3.49→ 7,102 held
- +1,093 sh · $3.8K
Talamo Joseph — Chief Financial Officer
- Granted1,093Common Stock, $0.0001 Par Value@ $3.49→ 2,239 held
Insiders on this tape
- Wesolowski John MPrincipal Accounting Officer
- Talamo JosephChief Financial Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.